- TradingView2026. 07. 31. 06:30
TEM: Q2 revenue up 22% to $382.5M; 2026 guidance raised; Personalis acquisition to boost MRD growth - TradingView
TEM: Q2 revenue up 22% to $382.5M; 2026 guidance raised; Personalis acquisition to boost MRD growth TradingView
- Investing.com South Africa2026. 07. 31. 03:28
Tempus AI faces earnings test after $1.5B Personalis deal By Investing.com - Investing.com South Africa
Tempus AI faces earnings test after $1.5B Personalis deal By Investing.com Investing.com South Africa
- MarketScale2026. 07. 30. 23:42
Tempus AI buys Personalis for $1.7B as digital health M&A su - MarketScale
Tempus AI buys Personalis for $1.7B as digital health M&A su MarketScale
- Mugglehead Investment Magazine2026. 07. 30. 11:04
Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform - Mugglehead Investment Magazine
Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform Mugglehead Investment Magazine
- stocktitan.net2026. 07. 30. 04:22
BlackRock (PSNL holder) discloses 5.9% beneficial stake in Personalis common stock - stocktitan.net
BlackRock (PSNL holder) discloses 5.9% beneficial stake in Personalis common stock stocktitan.net
- TheStreet2026. 07. 23. 09:37
Tempus makes $1.5B bet to corner cancer-test market
